27 related articles for article (PubMed ID: 22609845)
1. Striking the right balance.
Coltoff A
Lancet Haematol; 2024 Jun; 11(6):e402. PubMed ID: 38796190
[No Abstract] [Full Text] [Related]
2. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Tolar J; Deeg HJ; Arai S; Horwitz M; Antin JH; McCarty JM; Adams RH; Ewell M; Leifer ES; Gersten ID; Carter SL; Horowitz MM; Nakamura R; Pulsipher MA; Difronzo NL; Confer DL; Eapen M; Anderlini P
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1007-11. PubMed ID: 22546497
[TBL] [Abstract][Full Text] [Related]
3. Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning.
Yabe M; Shimizu T; Morimoto T; Koike T; Takakura H; Suganuma E; Sugiyama N; Kato S; Yabe H
Bone Marrow Transplant; 2011 Aug; 46(8):1148-50. PubMed ID: 20956956
[No Abstract] [Full Text] [Related]
4. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
Kang HJ; Shin HY; Choi HS; Ahn HS
Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
[TBL] [Abstract][Full Text] [Related]
5. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
[TBL] [Abstract][Full Text] [Related]
6. Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.
Hussein AA; Frangoul H
Pediatr Transplant; 2013 Jun; 17(4):326-7. PubMed ID: 23581860
[No Abstract] [Full Text] [Related]
7. Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia.
Ramos CA
Biol Blood Marrow Transplant; 2012 Jul; 18(7):975-6. PubMed ID: 22609845
[No Abstract] [Full Text] [Related]
8. [Non-myeloablative stem cell transplantation for non-malignant hematologic disorders].
Nakao S
Nihon Rinsho; 2003 Sep; 61(9):1596-600. PubMed ID: 14515730
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acquired severe aplastic anemia.
Katsanis E; Ramsay NK
Am J Pediatr Hematol Oncol; 1989; 11(3):360-7. PubMed ID: 2675662
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for acquired severe aplastic anemia.
Bacigalupo A
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1145-55. PubMed ID: 25459184
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of aplastic anemia].
Kleihauer E
Monatsschr Kinderheilkd; 1988 Dec; 136(12):772-8. PubMed ID: 3070360
[TBL] [Abstract][Full Text] [Related]
12. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
Führer M
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S97-100. PubMed ID: 18978755
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
